Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | 3 | 1 | 1 | 2 | 7 |
Hepatitis | D006505 | — | K75.9 | — | 3 | 2 | 2 | — | 6 |
Liver failure | D017093 | — | K72.9 | 1 | 2 | — | 2 | 1 | 5 |
Alcoholic liver diseases | D008108 | EFO_0008573 | K70 | — | 1 | 2 | 1 | 1 | 5 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | 2 | 1 | 2 | — | 4 |
Hepatitis b | D006509 | — | — | — | — | — | 2 | 1 | 3 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | 1 | — | 1 | — | 3 |
End stage liver disease | D058625 | EFO_1001311 | K72.1 | 1 | 2 | — | 1 | — | 3 |
Fibrosis | D005355 | — | — | — | 1 | — | 2 | — | 3 |
Cholestasis | D002779 | — | K83.1 | — | — | 1 | 2 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 1 | 3 | — | 2 | 6 |
Depression | D003863 | — | F33.9 | — | 3 | 1 | — | 3 | 6 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | 2 | — | 2 | 4 |
Fatty liver | D005234 | EFO_0003934 | — | — | — | 2 | — | 2 | 4 |
Hepatitis c | D006526 | — | B19.2 | — | 3 | 1 | — | — | 3 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | 2 | 1 | — | — | 2 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | 1 | — | 1 | 2 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | 1 | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | — | 1 |
Adenocarcinoma | D000230 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | 2 | 3 | — | — | 1 | 4 |
Cognitive dysfunction | D060825 | — | G31.84 | — | 2 | — | — | 1 | 3 |
Hepatic insufficiency | D048550 | — | — | 1 | 2 | — | — | 1 | 3 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 1 | — | — | 1 | 3 |
Chronic chemical and drug induced liver injury | D056487 | EFO_1000905 | — | 2 | 2 | — | — | — | 2 |
Acute-on-chronic liver failure | D065290 | — | — | 1 | 2 | — | — | — | 2 |
Chronic hepatitis | D006521 | — | K73.9 | — | 1 | — | — | — | 1 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | — | — | 1 |
Hot flashes | D019584 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | 2 | 3 |
Hyperhomocysteinemia | D020138 | — | — | 1 | — | — | — | 1 | 2 |
Recurrence | D012008 | — | — | 1 | — | — | — | 1 | 2 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | 1 | 2 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 4 | 4 |
Severe acute malnutrition | D000067011 | — | — | — | — | — | — | 3 | 3 |
Alcoholic fatty liver | D005235 | — | K70.0 | — | — | — | — | 2 | 2 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 1 | 1 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | — | 1 | 1 |
Mesenchymal stem cell transplantation | D045164 | — | — | — | — | — | — | 1 | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Anesthesia | D000758 | — | — | — | — | — | — | 1 | 1 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | — | — | — | 1 | 1 |
Pelvic organ prolapse | D056887 | EFO_0004710 | — | — | — | — | — | 1 | 1 |
Drug common name | Ademetionine |
INN | ademetionine |
Description | S-Adenosyl methionine (SAM), also known under the commercial names of SAMe, SAM-e, or AdoMet, is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation. Although these anabolic reactions occur throughout the body, most SAM is produced and consumed in the liver. More than 40 methyl transfers from SAM are known, to various substrates such as nucleic acids, proteins, lipids and secondary metabolites. It is made from adenosine triphosphate (ATP) and methionine by methionine adenosyltransferase. SAM was first discovered by Giulio Cantoni in 1952.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O |
PDB | — |
CAS-ID | 29908-03-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1088977 |
ChEBI ID | 67040 |
PubChem CID | 9865604 |
DrugBank | — |
UNII ID | 7LP2MPO46S (ChemIDplus, GSRS) |